National Health Investors, Inc. (NYSE:NHI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Analysts maintain a “Moderate Buy” consensus on National Health Investors, with five buys, two holds and one sell among eight covering brokerages. The average 12-month price target is $83.86 versus the reported share price of $71.23.
• Company insiders recently purchased shares, including the CEO’s 1,500-share buy and a director’s 890-share purchase. Institutional investors and hedge funds own 62.51% of NHI, while insiders hold 2.70%.
• NHI reported quarterly EPS of $1.19 on $121.32 million in revenue, up 1.6% year over year, and guided to fiscal 2026 EPS of $4.74–$4.79. The REIT also declared a quarterly dividend of $0.92 per share, equivalent to a 5.2% annualized yield.

National Health Investors, Inc. (NYSE:NHI - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight brokerages that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $83.8571.

Several brokerages have recently issued reports on NHI. Deutsche Bank Aktiengesellschaft reduced their price objective on National Health Investors from $85.00 to $80.00 and set a "hold" rating for the company in a research note on Thursday, June 25th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $94.00 target price on shares of National Health Investors in a research report on Wednesday, April 22nd. Truist Financial cut their price target on shares of National Health Investors from $89.00 to $81.00 and set a "buy" rating on the stock in a report on Friday, June 12th. Weiss Ratings lowered shares of National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research report on Friday, June 12th. Finally, BMO Capital Markets decreased their price objective on shares of National Health Investors from $90.00 to $80.00 and set an "outperform" rating for the company in a research note on Monday, June 15th.

Insiders Place Their Bets

In related news, Director Robert A. Mccabe, Jr. purchased 890 shares of the business's stock in a transaction on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director owned 44,159 shares of the company's stock, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the business's stock in a transaction on Friday, June 5th. The shares were bought at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders own 2.70% of the company's stock.

Institutional Trading of National Health Investors

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Renaissance Group LLC lifted its holdings in National Health Investors by 3.8% in the fourth quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust's stock valued at $245,000 after acquiring an additional 117 shares during the period. Captrust Financial Advisors grew its stake in shares of National Health Investors by 1.7% during the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust's stock worth $680,000 after purchasing an additional 146 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of National Health Investors by 34.3% during the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust's stock valued at $51,000 after purchasing an additional 160 shares in the last quarter. Assetmark Inc. increased its holdings in shares of National Health Investors by 13.5% during the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust's stock valued at $110,000 after purchasing an additional 161 shares in the last quarter. Finally, Inspire Investing LLC lifted its stake in shares of National Health Investors by 3.2% in the 1st quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust's stock valued at $510,000 after purchasing an additional 198 shares during the period. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Trading Up 0.7%

NYSE:NHI opened at $71.23 on Friday. National Health Investors has a 12 month low of $67.94 and a 12 month high of $91.38. The firm has a fifty day simple moving average of $75.23 and a 200-day simple moving average of $79.37. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $3.50 billion, a P/E ratio of 20.59, a PEG ratio of 3.24 and a beta of 0.51.

National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 11.01% and a net margin of 38.56%.The business's revenue was up 1.6% on a year-over-year basis. During the same quarter last year, the business earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities research analysts anticipate that National Health Investors will post 4.77 earnings per share for the current year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 5.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National Health Investors's dividend payout ratio (DPR) is 106.36%.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source